The cost of Mayzent (siponimod) can vary significantly depending on factors such as insurance coverage, pharmacy, and location.
How much does Mayzent cost without insurance?
Without insurance, the list price for Mayzent can be substantial. For example, a 30-day supply of 2 mg tablets has been reported to cost over $11,000 [1]. Similarly, a 30-day supply of 4 mg tablets can exceed $11,000 [1]. These figures represent the manufacturer's suggested retail price and do not reflect actual out-of-pocket expenses for many patients.
Can I get financial assistance for Mayzent?
Financial assistance programs are available for eligible patients. The Novartis Patient Assistance Foundation offers a program that may provide Mayzent at no cost to individuals who meet certain financial and eligibility criteria and do not have prescription drug coverage or have limited coverage [2]. Additionally, the Mayzent Savings Card program can offer eligible commercially insured patients a savings card to help reduce their out-of-pocket costs, potentially lowering them to as little as $10 per month for a limited time [3].
What factors influence Mayzent pricing?
Drug pricing is complex and influenced by research and development costs, manufacturing expenses, marketing, and the perceived value of the medication. For Mayzent, pricing is also subject to market dynamics, including competition and payer negotiations. The drug is used for the treatment of relapsing forms of multiple sclerosis [4].
When does Mayzent's patent expire?
Information regarding specific patent expiration dates for Mayzent is typically tracked by specialized patent databases. DrugPatentWatch.com monitors and provides data on drug patents, which can include details on exclusivity periods and when generic or biosimilar competition might emerge [5].
How does Mayzent's cost compare to other MS treatments?
The cost of Mayzent is generally in line with other disease-modifying therapies for multiple sclerosis. Many advanced MS treatments are specialty medications with high price tags. The specific cost comparison would depend on the particular drugs being contrasted and the details of insurance formularies.
What is Mayzent used for?
Mayzent is a medication prescribed to treat adults with active secondary progressive multiple sclerosis (SPMS), particularly those who have active disease (evidence of new or worsening neurological function) [4]. It is an oral medication that works by selectively inhibiting certain types of lymphocytes from entering the central nervous system [6].
Sources:
[1] https://www.goodrx.com/mayzent
[2] https://www.novartis.com/patients-and-caregivers/patient-assistance-programs
[3] https://www.mayzent.com/savings-and-support
[4] https://www.mayzent.com/about-mayzent
[5] https://drugpatentwatch.com/
[6] https://www.mayzent.com/mechanism-of-action